2022
DOI: 10.31577/sp.2022.01.839
|View full text |Cite
|
Sign up to set email alerts
|

Lower Adherence to Clotting Factor Replacement Therapy in Patients with Haemophilia Associated with More Depressive Symptoms: Two Centers Cross-Sectional Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…There is a strong rationale for MDTs to investigate even low-level depression and anxiety, with two recent studies observing that mild depressive symptoms were a primary driver of adherence to treatment among PwH. 32,33 More generally, effective monitoring could lead to earlier detection and intervention prior to any issues impacting significantly upon an individuals daily life and functioning. Even in MDTs lacking dedicated psychosocial support, many generic, validated screening tools (e.g., PHQ-9, GAD-7) are sensi-tive in capturing the impact of symptoms on daily activities and can be implemented by a non-specialist during routine appointments, allowing timely specialist referral, if needed.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There is a strong rationale for MDTs to investigate even low-level depression and anxiety, with two recent studies observing that mild depressive symptoms were a primary driver of adherence to treatment among PwH. 32,33 More generally, effective monitoring could lead to earlier detection and intervention prior to any issues impacting significantly upon an individuals daily life and functioning. Even in MDTs lacking dedicated psychosocial support, many generic, validated screening tools (e.g., PHQ-9, GAD-7) are sensi-tive in capturing the impact of symptoms on daily activities and can be implemented by a non-specialist during routine appointments, allowing timely specialist referral, if needed.…”
Section: Discussionmentioning
confidence: 99%
“…Information on subclinical (subthreshold) anxiety or depression (i.e., anxious or depressive symptoms that do not meet standardised diagnostic thresholds for minor/major depression or anxiety) 29–31 was not available for our analysis cohort, which may correlate with the relative absence of physician‐reported A/D among individuals self‐reporting slight/moderate A/D symptoms. There is a strong rationale for MDTs to investigate even low‐level depression and anxiety, with two recent studies observing that mild depressive symptoms were a primary driver of adherence to treatment among PwH 32,33 . More generally, effective monitoring could lead to earlier detection and intervention prior to any issues impacting significantly upon an individuals daily life and functioning.…”
Section: Discussionmentioning
confidence: 99%